Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,343 | 140 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $549.60 | 36 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $303.14 | 17 | $0 (2023) |
| Corium, LLC | $280.84 | 15 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $220.20 | 16 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $129.24 | 8 | $0 (2023) |
| ITI, Inc. | $102.40 | 5 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $84.82 | 5 | $0 (2022) |
| Lundbeck LLC | $78.15 | 5 | $0 (2023) |
| Harmony Biosciences LLC | $74.50 | 4 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $66.72 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $827.96 | 43 | Corium, LLC ($230.79) |
| 2022 | $823.63 | 54 | ABBVIE INC. ($196.15) |
| 2021 | $691.18 | 43 | AbbVie Inc. ($137.49) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 6 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $22.34 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 06/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2021 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Neurology | ||||||
| 05/03/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2021 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: NEUROLOGY | ||||||
| 03/23/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 71 | 89 | $13,800 | $5,126 |
| 2022 | 2 | 117 | 251 | $31,400 | $16,959 |
| 2021 | 2 | 124 | 294 | $36,750 | $19,807 |
| 2020 | 2 | 147 | 404 | $45,475 | $25,464 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 50 | $11,240 | $4,231 | 37.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 19 | 19 | $1,960 | $814.01 | 41.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 12 | 20 | $600.00 | $81.20 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 126 | $18,900 | $10,926 | 57.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 58 | 125 | $12,500 | $6,033 | 48.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 147 | $22,050 | $12,764 | 57.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 62 | 147 | $14,700 | $7,043 | 47.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 203 | $25,375 | $15,357 | 60.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 73 | 201 | $20,100 | $10,107 | 50.3% |
About Christine Abt, APN, CS
Christine Abt, APN, CS is a Psychiatric/Mental Health, Community healthcare provider based in Carol Stream, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073546016.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christine Abt, APN, CS has received a total of $2,343 in payments from pharmaceutical and medical device companies, with $827.96 received in 2023. These payments were reported across 140 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,343).
As a Medicare-enrolled provider, Abt has provided services to 459 Medicare beneficiaries, totaling 1,038 services with total Medicare billing of $67,355. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health, Community
- Other Specialties Community
- Location Carol Stream, IL
- Active Since 07/09/2006
- Last Updated 04/24/2015
- Taxonomy Code 364SP0812X
- Entity Type Individual
- NPI Number 1073546016
Products in Payments
- VRAYLAR (Drug) $549.60
- REXULTI (Drug) $298.35
- Azstarys (Drug) $230.79
- INVEGA SUSTENNA (Drug) $208.61
- TRINTELLIX (Drug) $129.24
- CAPLYTA (Drug) $102.40
- SPRAVATO (Drug) $94.53
- LATUDA (Drug) $84.82
- Wakix (Drug) $74.50
- AUSTEDO (Drug) $66.72
- INGREZZA (Drug) $60.34
- SUNOSI (Drug) $59.83
- ARISTADA (Drug) $50.71
- AZSTARYS (Drug) $50.05
- Dayvigo (Drug) $47.40
- ADHANSIA XR (Drug) $34.39
- QELBREE (Drug) $32.20
- Auvelity (Drug) $25.96
- WELLBUTRIN (Drug) $20.94
- Nuedexta (Drug) $20.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.